LobbyingHeartflow lobbying by quarter
Heartflow HTFL's latest lobbying report covers Q2 2026, at $180K. The four quarters Q4 2025–Q3 2026 total $510K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Health Issues.
HeartflowHTFL
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $510K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $210K | 3 |
| Q1 2023 | $220K | 3 |
| Q2 2023 | $230K | 3 |
| Q3 2023 | $200K | 3 |
| Q4 2023 | $150K | 3 |
| Q1 2024 | $80K | 4 |
| Q2 2024 | $160K | 4 |
| Q3 2024 | $160K | 4 |
| Q4 2024 | $150K | 4 |
| Q1 2025 | $160K | 4 |
| Q2 2025 | $180K | 4 |
| Q3 2025 | $180K | 4 |
| Q4 2025 | $180K | 4 |
| Q1 2026 | $150K | 3 |
| Q2 2026 | $180K | 3 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$2.4M · 34 reports
- Health issues$100K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES31 reports
- SENATE31 reports
- Health & Human Services, Dept of (HHS)6 reports
- Centers For Medicare and Medicaid Services (CMS)5 reports
- Food & Drug Administration (FDA)3 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseHeartflow | $1.4M | 15 quarters |
| Baker Donelson Bearman Caldwell & Berkowitz | $660K | 13 quarters |
| DB3 | $400K | 8 quarters |
| Kountoupes Denham Carr & Reid | $140K | 2 quarters |
| Squire Patton Boggs | $0 | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JENNIFER SUMMA | Former SF Investigative Counsel (detailed from CMS) | Q4 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/21for Q2 | In-house | $100K |
| 07/09for Q2 | Squire Patton Boggs | Under $5,000 |
| 07/08for Q2 | Kountoupes Denham Carr & Reid | $80K |
| 06/15for Q1 | In-house | $90K |
| 04/21for Q1 | In-house | $60K |
| 04/08for Q1 | Kountoupes Denham Carr & Reid | $60K |
| 04/06for Q1 | Squire Patton Boggs | Under $5,000 |
| 03/19for Q1 | Kountoupes Denham Carr & Reid | Under $5,000 |
| 01/20for Q4 2025 | In-house | $90K |
| 01/20for Q4 2025 | DB3 | $60K |
| 01/14for Q4 2025 | Baker Donelson Bearman Caldwell & Berkowitz | $30K |
| 01/12for Q4 2025 | Squire Patton Boggs | Under $5,000 |
| 25/10/20for Q3 2025 | DB3 | $60K |
| 25/10/20for Q3 2025 | In-house | $90K |
| 25/10/17for Q3 2025 | Baker Donelson Bearman Caldwell & Berkowitz | $30K |
| 25/10/13for Q3 2025 | Squire Patton Boggs | Under $5,000 |
| 25/07/18for Q2 2025 | In-house | $90K |
| 25/07/18for Q3 2025 | In-house | Under $5,000 |
| 25/07/18for Q2 2025 | DB3 | $60K |
| 25/07/09for Q2 2025 | Baker Donelson Bearman Caldwell & Berkowitz | $30K |